#egfr-inhibitors — top 20, last 14d
| 1 | ℹ |
Osimertinib, platinum, and etoposide for patients with metastatic EGFR/TP53/RB1-mutant lung cancers at risk for histological transformation.
(science.org)
|
Science Translational Medicine 2026-11-11 | #transcriptomics #lung cancer #plasticity #drug resistance #egfr-inhibitors |